AG NPP709 is at present available on the market; having said that, no study has investigated the impact of AG NPP709 in sufferers with COPD. Thus, the intention of the analyze was To judge the efficacy of AG NPP709 in patients with Continual bronchitis type COPD.Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis e